Drug Trial Failure Continues to Sting Kamada on Wall Street


Demandware Inc (NYSE:DWRE), Senomyx Inc. (NASDAQ:SNMX) and Gogo Inc (NASDAQ:GOGO) are starting off the week strong and are today’s top gainers midday. The losers are dELiA*s, Inc. (NASDAQ:DLIA), QuickLogic Corporation (NASDAQ:QUIK) and Kamada Ltd (NASDAQ:KMDA).

Soros Picks Senomyx, Gogo Soar

Demandware Inc (NYSE:DWRE) is today’s top gainer, its price surging +10.94%. A Julian Robertson holding, the e-commerce solutions provider is up +5.19% since reporting results on May 6th.

Following Demandware on this Monday’s list of midday gainers is Senomyx Inc. (NASDAQ:SNMX), up +10.38%. The company announced the two-year extension of an agreement with Pepsi – likely the reason for the price surge of this George Soros pick.

Last up is Gogo Inc (NASDAQ:GOGO), which got a +9.28% boost on the stock market today. UBS upgraded its rating of the in-flight telecommunications provider from neutral to buy and also set its target price at $26. Soros added Gogo to his portfolio in Q1.

Kamada Falls

dELiA*s, Inc. (NASDAQ:DLIA) slipped -8.88% midday today. The retailer has been in the Tiger Global portfolio for two quarters.

The share price of QuickLogic Corporation (NASDAQ:QUIK) -6.81% by midday, despite having started off strong this morning. George Soros initiated a position in QUIK during the first quarter of 2014.

Also on the losing end of the market this Monday is Kamada Ltd (NASDAQ:KMDA), down -6.50%. The Israeli drugmaker announced that one of its products had failed a key trial last week, and its stock continues to suffer the fall-out. Billionaire John Paulson has a position in the company.

For exclusive info on hedge funds and the latest news from value investing world at only a few dollars a month check out ValueWalk Premium right here.

Multiple people interested? Check out our new corporate plan right here (We are currently offering a major discount)

About the Author

iBillionaire provides access to the investment data and strategies of the world's most successful self-made billionaires. Mobile app available for iOS and Android. Maker of the iBillionaire Index (IBLN). More at www.iBillionaire.me.

Be the first to comment on "Drug Trial Failure Continues to Sting Kamada on Wall Street"

Leave a comment

Your email address will not be published.